StonvexLoading…
StonvexStonvexStonvexCore line items from VVOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.44M | $15.03M | $13.80M | $16.02M |
Operating Income | $-19.89M | $-11.17M | $-17.30M | $-25.03M |
Net Income | $-21.17M | $-11.14M | $-13.58M | $-23.84M |
EPS (Diluted) | $-2.07 | $-2.22 | $-11.14 | $-25.90 |
Total Assets | $25.15M | $15.28M | $10.73M | $13.72M |
Total Liabilities | $26.70M | $7.33M | $10.32M | $8.92M |
Cash & Equivalents | $2.03M | $6.26M | $1.64M | $3.52M |
Free Cash Flow OCF − CapEx | $-17.60M | $-13.26M | $-12.75M | $-20.51M |
Shares Outstanding | 9.29M | 5.89M | 1.83M | 920.59K |